Estimating cancer incidence, prevalence, and the number of cancer patients treated with antitumor therapy in 2015 and 2020 -  analysis of the Czech National Cancer Registry.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F15%3A%230001099" target="_blank" >RIV/00064190:_____/15:#0001099 - isvavai.cz</a>

Alternative codes found

RIV/00216224:14110/15:00087440

Result on the web

<a href="http://www.prolekare.cz/en/clinical-oncology-article/estimating-cancer-incidence-prevalence-and-the-number-of-cancer-patients-treated-with-anti-tumor-therapy-in-51231?confirm_rules=1" target="_blank" >http://www.prolekare.cz/en/clinical-oncology-article/estimating-cancer-incidence-prevalence-and-the-number-of-cancer-patients-treated-with-anti-tumor-therapy-in-51231?confirm_rules=1</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.14735/amko201530" target="_blank" >10.14735/amko201530</a>

Result language

angličtina

Original language name

Estimating cancer incidence, prevalence, and the number of cancer patients treated with antitumor therapy in 2015 and 2020 -  analysis of the Czech National Cancer Registry.

Original language description

Cancer burden in the Czech population ranks among the highest worldwide, which introduces a strong need for a prospective modelling of cancer incidence and prevalence rates. Moreover, a prediction of number of cancer patients requiring active antitumor therapy is also an important issue. This paper presents the stage-specific predictions of cancer incidence and prevalence, and the stage- and region-specific patients requiring active antitumor therapy for the most common cancer diagnoses in the Czech Republic for years 2015 and 2020. The stage-specific estimates are also presented with regard to the treatment phase as newly diagnosed patients, patients treated for non-terminal recurrence, and patients treated for terminal recurrence.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

<a href="/en/project/NT13660" target="_blank" >NT13660: Quality evaluation of multimodal treatment in patients with colorectal liver metastatic disease: Mutlicentric study within Czech complex oncology centres</a><br>

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Klinická onkologie

ISSN

0862-495X

e-ISSN

—

Volume of the periodical

28

Issue of the periodical within the volume

1

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

14

Pages from-to

30-43

UT code for WoS article

—

EID of the result in the Scopus database

—